For the anti-diabetic medications (ADMs), the number of patients prescribed an ADM in December 2023 remained about the same as the number in both November 2023 and October 2023
Watch the Ozempic trap. Even a won off-label Ozempic appeal can be clawed back later, since it stays off-label
David Rind, chief medical officer for the Institute for Clinical and Economic Review, which estimates the value of drugs
Lipo C Injections Recovery & Results Lipo C injections do not require recovery or downtime
A Groundbreaking Approval In late 2024, the FDAs approval of Zepbound for the treatment of OSA marks the first time a GLP-1 receptor agonist has been cleared for use outside of weight management and diabetes treatment
These medications, hailed for their ability to promote weight loss and stabilize blood sugar levels, have garnered widespread attention and acclaim